Table: Rohto -2022/23 parent results
May 12 (Reuters)-
Rohto Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 115.36 101.21
(+14.0 pct)
Operating 18.61 16.72
(+11.3 pct)
Recurring 22.46 17.52
(+28.2 pct)
Net 16.57 13.04
(+27.1 pct)
EPS 72.62 yen 57.14 yen
EPS Diluted 72.42 yen 56.97 yen
Ann Div 36.00 yen 24.00 yen
-Q2 Div 20.00 yen 15.00 yen 12.00 yen
-Q4 Div 12.00 yen 21.00 yen 12.00 yen
NOTE - Rohto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T